Harmony Biosciences Holdings, Inc. - Common Stock (HRMY)

CUSIP: 413197104

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
-2,211
SEC-reported price per share
$39.26
Number of holders
27
Value change
-$65,135
Number of buys
12
Number of sells
11
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
57,940,610

Security key

413197104

Report period

Q3 2026

Institutions

27

Top holders

10

Ownership snapshot

Top reported holders of HRMY - Harmony Biosciences Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
4/15
Latest evidence
30 Jun 2026
13F 13D/G 3/4/5 Lead comparable stake: 11% 11 rows are not safely comparable across share classes. 13D/G row: BlackRock, Inc. Showing 1-6 of 15 holder rows.

Quick read

BlackRock, Inc. leads the comparable SEC ownership view at 11%.

4 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership Top 4
BlackRock, Inc. 11%
Marshman Fund Trust II 11%
FMR LLC 5.4%
VANGUARD PORTFOLIO MANAGEMENT LLC 5.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock, Inc.
13F 13D/G
Company
11%
Reported 13D/G · 30 Jun 2026
$258,582,545
7,101,965 shares
— 30 Jun 2026
Marshman Fund Trust II
3/4/5 13D/G
10%+ Owner
11%
Reported 13D/G · 31 Dec 2024
$183,364,064
6,051,120 shares
— 01 Nov 2024
FMR LLC
13F 13D/G
Company
5.4%
Reported 13D/G · 31 Dec 2025
$130,133,520
3,574,115 shares
— 30 Jun 2026
VANGUARD PORTFOLIO MANAGEMENT LLC
13F 13D/G
Company · Vanguard Portfolio Management
5.1%
Reported 13D/G · 30 Jun 2026
$104,878,604
2,880,489 shares
— 30 Jun 2026
Valor IV Pharma Holdings, LLC
3/4/5
10%+ Owner
—
denominator unverified
$834,732
23,714 shares
— 28 Aug 2025
AMERICAN CENTURY COMPANIES INC
13F
Company
13F
—
denominator unverified
$92,463,632
2,539,512 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
27
Shares
617,684
Rows available
27
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
326
Q3 2026 holders
27
Holder diff
-299
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .